The DOI matches its Crossref record; 167 of the 167 references it cites were found in a registry or an index.
Molecular genetics of early-onset Alzheimer’s disease revisited
Open accessAbstract
As the discovery of the Alzheimer's disease (AD) genes, APP, PSEN1, and PSEN2, in families with autosomal dominant early-onset AD (EOAD), gene discovery in familial EOAD came more or less to a standstill. Only 5% of EOAD patients are carrying a pathogenic mutation in one of the AD genes or a apolipoprotein E (APOE) risk allele ε4, most of EOAD patients remain unexplained. Here, we aimed at summarizing the current knowledge of EOAD genetics and its role in ongoing approaches to understand the biology of AD and disease symptomatology as well as developing new therapeutics. Next, we explored the possible molecular mechanisms that might underlie the missing genetic etiology of EOAD and discussed how the use of massive parallel sequencing technologies triggered novel gene discoveries. To conclude, we commented on the relevance of reinvestigating EOAD patients as a means to explore potential new avenues for translational research and therapeutic discoveries.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“These rare mutations cause the aggregation of amyloid proteins, leading to the progression of early onset AD.”
From Role of neuroinflammation in neurodegeneration development (2023) · cites this paper as [157]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“But it was until 1980s that three genes, including APP, PSEN1, and PSEN2, were found to be responsible for early onset AD.157”
From Role of neuroinflammation in neurodegeneration development (2023) · cites this paper as [157]
Experimental — accuracy not yet measuredIn the citing paper
“PSEN2 mutations are much rarer, with only around 30 mutations identified in ADAD families [2].”
From Genetic architecture of Alzheimer's disease (2020) · cites this paper as [2]
In the citing paper
“A majority of ADAD families carry a pathogenic mutation in one of three genes: APP, presenilin 1 (PSEN1), or presenilin 2 (PSEN2) [2, 33].”
From Genetic architecture of Alzheimer's disease (2020) · cites this paper as [2]
In the citing paper
“To date, more than 50 highly penetrant mutations have been identified in APP [2].”
From Genetic architecture of Alzheimer's disease (2020) · cites this paper as [2]
In the citing paper
“ADAD is very rare, accounting for less than <1% of all cases of AD [2, 31–33]”
From Genetic architecture of Alzheimer's disease (2020) · cites this paper as [2]
In the citing paper
“While mutations in these genes are the most well-studied mutations associated with EOAD, it is estimated that a significant portion of EOAD remains unexplained genetically [2].”
From Genetic architecture of Alzheimer's disease (2020) · cites this paper as [2]
In the citing paper
“Gene duplications of APP are well-known to cause AD, with as many as 25 duplications of variable length associated with AD in EOAD families [2]”
From Genetic architecture of Alzheimer's disease (2020) · cites this paper as [2]
In the citing paper
“The large variability in the age at onset of AD symptoms even among families who share common pathogenic mutations [31]”
From Genetic architecture of Alzheimer's disease (2020) · cites this paper as [31]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
McKhann, G. M., Knopman, D. S., Chertkow, H., Hyman, B. T., Jack, C. R., Kawas, C. H., Klunk, W. E., Koroshetz, W. J., Manly, J. J., Mayeux, R., et al. (2011) · Alzheimer's & Dementia · doi:10.1016/j.jalz.2011.03.005 · Cited by 18,657
Corder, E. H., Saunders, A. M., Strittmatter, W. J., Schmechel, D. E., Gaskell, P. C., Small, G. W., Roses, A. D., Haines, J. L., & Pericak-Vance, M. A. (1993) · Science · doi:10.1126/science.8346443 · Cited by 9,429
Alzheimer's disease: the amyloid cascade hypothesis
Hardy, J. A., & Higgins, G. A. (1992) · Science · doi:10.1126/science.1566067 · Cited by 7,484
Glenner, G. G., & Wong, C. W. (1984) · Biochemical and Biophysical Research Communications · doi:10.1016/s0006-291x(84)80190-4 · Cited by 5,404
Goate, A., Chartier-Harlin, M.-C., Mullan, M., Brown, J., Crawford, F., Fidani, L., Giuffra, L., Haynes, A., Irving, N., James, L., et al. (1991) · Nature · doi:10.1038/349704a0 · Cited by 4,659
The precursor of Alzheimer's disease amyloid A4 protein resembles a cell-surface receptor
Kang, J., Lemaire, H.-G., Unterbeck, A., Salbaum, J. M., Masters, C. L., Grzeschik, K.-H., Multhaup, G., Beyreuther, K., & Müller-Hill, B. (1987) · Nature · doi:10.1038/325733a0 · Cited by 4,619
Amyloid plaque core protein in Alzheimer disease and Down syndrome.
Masters, C. L., Simms, G., Weinman, N. A., Multhaup, G., McDonald, B. L., & Beyreuther, K. (1985) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.82.12.4245 · Cited by 4,431
Meta-Analysis of 74,046 Individuals Identifies 11 New Susceptibility Loci for Alzheimer’s Disease
(EADI), E. A. D. I., Lambert, J.-C., (GERAD), G. A. E. R. I. A. D., Alzheimer's Disease Genetic Consortium (ADGC), (CHARGE), C. F. H. A. A. R. I. G. E., Ibrahim-Verbaas, C. A., Harold, D., Naj, A. C., Sims, R., Bellenguez, C., et al. (2013) · Nature Genetics · doi:10.1038/ng.2802 · Cited by 4,336
Self-citationStrittmatter, W. J., Saunders, A. M., Schmechel, D., Pericak-Vance, M., Enghild, J., Salvesen, G. S., & Roses, A. D. (1993) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.90.5.1977 · Cited by 4,268
Cloning of a gene bearing missense mutations in early-onset familial Alzheimer's disease
Sherrington, R., Rogaev, E. I., Liang, Y., Rogaeva, E. A., Levesque, G., Ikeda, M., Chi, H., Lin, C., Li, G., Holman, K., et al. (1995) · Nature · doi:10.1038/375754a0 · Cited by 4,051
Flagged first, then by citations
Cited by
Sorted by citations
Items 201–300 of 617
Pang, S., Li, S., Cheng, H., Luo, Z., Qi, X., Guan, F., Dong, W., Gao, S., Liu, N., Gao, X., et al. (2023) · Frontiers in Molecular Neuroscience · doi:10.3389/fnmol.2022.1025066 · Cited by 23
Alternative hypotheses related to Alzheimer’s disease
Cubinkova, V., Valachova, B., Uhrinova, I., Brezováková, V., Smolek, T., Jadhav, S., & Žilka, N. (2018) · Bratislavské lekárske listy/Bratislava medical journal · doi:10.4149/bll_2018_039 · Cited by 25
Epileptic Mechanisms Shared by Alzheimer’s Disease: Viewed via the Unique Lens of Genetic Epilepsy
Kang, J. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22137133 · Cited by 23
Zeng, L., Jiang, H., Ashraf, G. M., Li, Z., & Liu, R. (2021) · Neural Regeneration Research · doi:10.4103/1673-5374.308104 · Cited by 22
Wasilewski, D., Villalba‐Moreno, N. D., Stange, I., Glatzel, M., Falla, D. S., & Krasemann, S. (2022) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2021.739411 · Cited by 23
CD33 rs2455069 SNP: Correlation with Alzheimer’s Disease and Hypothesis of Functional Role
Tortora, F., Rendina, A., Angiolillo, A., Costanzo, A. D., Aniello, F., Donizetti, A., Febbraio, F., & Vitale, E. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23073629 · Cited by 24
Serotonin Receptors as a Potential Target in the Treatment of Alzheimer’s Disease
Eremin, D. V., Kondaurova, E. M., Rodnyy, A. Y., Molobekova, C. A., Kudlay, D. A., & Naumenko, V. S. (2023) · Biochemistry (Moscow) · doi:10.1134/s0006297923120064 · Cited by 23
Wingo, A. P., Liu, Y., Vattathil, S. M., Gerasimov, E. S., Mei, Z., Ravindran, S. P., Liu, J., Shantaraman, A., Seifar, F., Wang, E., et al. (2025) · Nature Genetics · doi:10.1038/s41588-025-02291-2 · Cited by 21
López-Toledo, G., Silva‐Lucero, M., Herrera‐Díaz, J., García, D.-E., Arias‐Montaño, J., & Cárdenas‐Aguayo, M. D. C. (2022) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2022.921573 · Cited by 20
Formulation strategies for nose-to-brain drug delivery in Alzheimer's disease
Vohra, M., Amir, M., Sharma, A., & Wadhwa, S. (2023) · Health Sciences Review · doi:10.1016/j.hsr.2023.100075 · Cited by 21
Transgenic Mouse Models for the Study of Neurodegenerative Diseases
Marín‐Moreno, A., Canoyra, S., Fernández‐Borges, N., Espinosa, J. C., & Torres, J. M. (2023) · Frontiers in Bioscience-Landmark · doi:10.31083/j.fbl2801021 · Cited by 21
Afram, E., Lauritzen, I., Bourgeois, A., Manaa, W. E., Duplan, E., Chami, M., Valverde, A., Bauer, C., Pardossi‐Piquard, R., & Checler, F. (2023) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-023-04737-4 · Cited by 26
Hyperphosphorylated Tau Inflicts Intracellular Stress Responses that Are Mitigated by Apomorphine
Song, Z., Wang, K., Hagar, H. C., Chen, H., Kuan, C.-Y., Zhang, K., & Kuo, M. (2023) · Molecular Neurobiology · doi:10.1007/s12035-023-03689-x · Cited by 23
Multiple Aggregation Pathways in Human γS-Crystallin and Its Aggregation-Prone G18V Variant
Roskamp, K. W., Montelongo, D. M., Anorma, C., Bandak, D. N., Chua, J. A., Malecha, K. T., & Martin, R. W. (2017) · Investigative Ophthalmology & Visual Science · doi:10.1167/iovs.16-20621 · Cited by 21
Camargo, L. C., Campos, G. A. A., Galante, P., Biolchi, A. M., Gonçalves, J. C., Lopes, K. S., & Mortari, M. R. (2017) · Neuropeptides · doi:10.1016/j.npep.2017.11.010 · Cited by 21
Design and Reporting Considerations for Genetic Screening Tests
Hagenkord, J. M., Funke, B., Qian, E., Hegde, M., Jacobs, K. B., Ferber, M. J., Lebo, M. S., Buchanan, A. H., & Bick, D. P. (2020) · Journal of Molecular Diagnostics · doi:10.1016/j.jmoldx.2020.01.014 · Cited by 21
Dong, L., Mao, C., Liu, C., Li, J., Huang, X., Wang, J., Lei, D., Chu, S., Sha, L., Xu, Q., et al. (2021) · Journal of Alzheimer s Disease · doi:10.3233/jad-215067 · Cited by 21
Kim, J. P., Kim, B.-H., Bice, P. J., Seo, S. W., Bennett, D. A., Saykin, A. J., & Nho, K. T. (2022) · Biological Psychiatry · doi:10.1016/j.biopsych.2022.06.020 · Cited by 21
Hu, X., Peng, J., Tang, W., Xia, Y., & Song, P. (2023) · BioScience Trends · doi:10.5582/bst.2023.01221 · Cited by 19
Future horizons in Alzheimer's disease research
Wısnıewskı, T., & Drummond, E. (2019) · Progress in molecular biology and translational science · doi:10.1016/bs.pmbts.2019.08.001 · Cited by 20
The Genetics of Alzheimer’s Disease in the Chinese Population
Gan, C., Zhang, T., & Lee, T. H. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21072381 · Cited by 21
Pathogenesis, Animal Models, and Drug Discovery of Alzheimer’s Disease
Xia, Z.-D., Ma, R.-X., Wen, J.-F., Zhai, Y.-F., Wang, Y.-Q., Wang, F.-Y., Liu, D., Zhao, X.-L., Sun, B., Jia, P., et al. (2023) · Journal of Alzheimer's Disease · doi:10.3233/jad-230326 · Cited by 19
Phenotype and imaging features associated with APP duplications
Grangeon, L., Charbonnier, C., Zaréa, A., Rousseau, S., Rovelet‐Lecrux, A., Bendetowicz, D., Lemaitre, M., Malrain, C., Quillard‐Muraine, M., Cassinari, K., et al. (2023) · Alzheimer s Research & Therapy · doi:10.1186/s13195-023-01172-2 · Cited by 18
Genetic Insights into Alzheimer's Disease
Latimer, C. S., Lucot, K. L., Keene, C. D., Cholerton, B., & Montine, T. J. (2021) · Annual Review of Pathology Mechanisms of Disease · doi:10.1146/annurev-pathmechdis-012419-032551 · Cited by 20
Jayadev, S. (2022) · CONTINUUM Lifelong Learning in Neurology · doi:10.1212/con.0000000000001125 · Cited by 21
Selenium and Alzheimer's disease
Gu, J., Gu, J., & Yu, L. (2024) · Chinese Chemical Letters · doi:10.1016/j.cclet.2024.110727 · Cited by 18
Jin, Z., Lu, Y., Tang, H., & Cui, H. (2025) · Alzheimer s & Dementia · doi:10.1002/alz.70472 · Cited by 24
Nanomedicine against Alzheimer’s and Parkinson’s Disease
Tandon, A., Singh, S. J., & Chaturvedi, R. K. (2020) · Current Pharmaceutical Design · doi:10.2174/1381612826666201021140904 · Cited by 20
Minding the Gap: Exploring Neuroinflammatory and Microglial Sex Differences in Alzheimer’s Disease
Reed-Geaghan, E. G., & Keller-Norrell, P. R. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms242417377 · Cited by 19
Grant, W. B. (2024) · Journal of Alzheimer s Disease · doi:10.3233/jad-240658 · Cited by 17
A pathogenic PSEN2 p.His169Asn mutation associated with early-onset Alzheimer’s disease
Giau, V. V., Pyun, J., Bagyinszky, E., An, S. S. A., & Kim, S. (2018) · Clinical Interventions in Aging · doi:10.2147/cia.s170374 · Cited by 18
Exome sequencing revealed PDE11A as a novel candidate gene for early-onset Alzheimer’s disease
Qin, W., Zhou, A., Zuo, X., Jia, L., Wei, C., Wang, Q., Wang, F., Li, F., Wang, Q., Li, Y., et al. (2021) · Human Molecular Genetics · doi:10.1093/hmg/ddab090 · Cited by 16
Genomics of speech and language disorders
Guerra, J., & Cacabelos, R. (2019) · Journal of Translational Genetics and Genomics · doi:10.20517/jtgg.2018.03 · Cited by 19
Alzheimer’s disease basics: we all should know
Das, S. K. (2025) · Neurological Research · doi:10.1080/01616412.2025.2529560 · Cited by 19
Bhattacharya, A., Izzo, A., Mollo, N., Napolitano, F., Limone, A., Margheri, F., Mocali, A., Minopoli, G., Bianco, A. L., Maggio, F. D., et al. (2020) · Journal of Personalized Medicine · doi:10.3390/jpm10040232 · Cited by 17
AP2S1 regulates APP degradation through late endosome–lysosome fusion in cells and APP / PS1 mice
Wen, Q., Luo, B., Xie, X., Zhou, G., Chen, J., Li, S., Liu, Y., Xie, S., Chen, L., Li, K., et al. (2022) · Traffic · doi:10.1111/tra.12874 · Cited by 19
Zhang, Y., Xie, X., Chen, B., Pan, L., Li, J., Wang, W., Wang, J., Tang, R., Huang, Q., Chen, X., et al. (2023) · Genes & Diseases · doi:10.1016/j.gendis.2023.02.051 · Cited by 19
Tian, Y., Shang, Q., Liang, R., & Viles, J. H. (2024) · JACS Au · doi:10.1021/jacsau.3c00687 · Cited by 18
Schedin‐Weiss, S., Nilsson, P., Matton, A., Axenhus, M., Sekiguchi, M., Saito, T., Winblad, B. G., Saido, T. C., & Tjernberg, L. O. (2020) · Journal of Alzheimer s Disease · doi:10.3233/jad-200028 · Cited by 17
Toward refining Alzheimer's disease into overlapping subgroups
Hascup, E. R., & Hascup, K. N. (2020) · Alzheimer s & Dementia Translational Research & Clinical Interventions · doi:10.1002/trc2.12070 · Cited by 16
Bossaerts, L., Hens, E., Hanseeuw, B. J., Vandenberghe, R. R., Cras, P. P., Deyn, P. P. D., Engelborghs, S., & Broeckhoven, C. V. (2021) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2021.04.023 · Cited by 17
Šerý, O., Zeman, T., Sheardová, K., Vyhnálek, M., Marková, H., Laczó, J., Lochman, J., Králík, P., Vrzalová, K., Dziedzinská, R., et al. (2022) · Scientific Reports · doi:10.1038/s41598-022-15299-z · Cited by 17
Wu, M., Shi, H., He, Y., Li, Y., Qu, X., Zhang, J., Wang, Z.-J., Cai, H.-Y., & Qi, J. (2017) · Journal of Alzheimer s Disease · doi:10.3233/jad-170307 · Cited by 17
Alatrany, A. S., Khan, W., Hussain, A. J., Al‐Jumeily, D., & Initiative, A. D. N. (2023) · PLoS ONE · doi:10.1371/journal.pone.0283712 · Cited by 16
Cacace, R., Zhou, L., de Craen, E. H. V., Buist, A., Hoogmartens, J., Sieben, A., Cras, P. P., Vandenberghe, R. R., Deyn, P. P. D., Oehlrich, D., et al. (2023) · Molecular Psychiatry · doi:10.1038/s41380-023-02166-0 · Cited by 16
Self-citationGenome‐wide meta‐analysis identifies ancestry‐specific loci for Alzheimer's disease
Ge, Y., Chen, S., Wu, B., Zhang, Y.-R., Wang, J., He, X., Liu, W., Chen, Y., Ou, Y., Shen, X., et al. (2024) · Alzheimer s & Dementia · doi:10.1002/alz.14121 · Cited by 15
A review of the roles of pathogens in Alzheimer’s disease
Zhao, M., Wang, Y., Shen, Y., Wei, C., Zhang, G., & Sun, L. (2024) · Frontiers in Neuroscience · doi:10.3389/fnins.2024.1439055 · Cited by 18
Park, J., An, S. S. A., Giau, V. V., Shim, K., Youn, Y. C., Bagyinszky, E., & Kim, S. (2017) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2017.04.012 · Cited by 16
Hamezah, H. S., Durani, L. W., Yanagisawa, D., Ibrahim, N. F., Aizat, W. M., Makpol, S., Ngah, W. Z. W., Damanhuri, H. A., & Tooyama, I. (2019) · Journal of Alzheimer s Disease · doi:10.3233/jad-181171 · Cited by 16
Cognition and the Predictive Utility of Three Risk Scores in an Ethnically Diverse Sample
Torres-Marrero, S. D., Alexander, A. M., O’Bryant, S. E., & Medina, L. D. (2020) · Journal of Alzheimer s Disease · doi:10.3233/jad-191284 · Cited by 15
Two Novel Mutations and a de novo Mutation in PSEN1 in Early-onset Alzheimer’s Disease
Li, Y., Yang, Z.-H., Zhang, Y., Yang, J., Shang, D., Zhang, S., Wu, J. W., Ji, Y., Zhao, L., Shi, C., et al. (2018) · Aging and Disease · doi:10.14336/ad.2018.1109 · Cited by 16
Peripheral TREM2 mRNA levels in early and late-onset Alzheimer disease’s patients
Güven, G., Bılgıç, B., Samancı, B., Gurvit, H. I., Hanağası, H. A., Dönmez, Ç., Aslan, R., Lohmann, E., & Erginel‐Ünaltuna, N. (2020) · Molecular Biology Reports · doi:10.1007/s11033-020-05661-7 · Cited by 15
Chronic inflammation evoked by pathogenic stimulus during carcinogenesis
Brücher, B. L. D. M., & Jamall, I. S. (2019) · 4open · doi:10.1051/fopen/2018006 · Cited by 16
Jester, H. M., Gosrani, S. P., Ding, H., Zhou, X., Ko, M., & Ma, T. (2022) · Journal of Alzheimer s Disease · doi:10.3233/jad-215303 · Cited by 15
Nan, H., Chu, M. K., Jiang, D., Liang, W., Li, Y., Wu, Y., Wang, Z., & Wu, L. (2025) · Alzheimer s Research & Therapy · doi:10.1186/s13195-025-01702-0 · Cited by 17
Park, J. E., Kim, H. J., Kim, Y.-E., Jang, H., Cho, S. H., Kim, S. J., Na, D. L., Won, H., Ki, C., & Seo, S. W. (2019) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2019.05.009 · Cited by 15
Bocharov, E. V., Nadezhdin, K. D., Urban, A. S., Volynsky, P. E., Pavlov, K. V., Efremov, R. G., Arseniev, A. S., & Bocharova, O. V. (2019) · ACS Chemical Biology · doi:10.1021/acschembio.9b00309 · Cited by 15
NDUFA1 p.Gly32Arg variant in early-onset dementia
Huttula, S., Väyrynen, H., Helisalmi, S., Kytövuori, L., Luukkainen, L., Hiltunen, M., Remes, A. M., & Krüger, J. (2022) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2021.09.026 · Cited by 15
Liang, R., Tian, Y., & Viles, J. H. (2022) · Journal of Biological Chemistry · doi:10.1016/j.jbc.2022.102071 · Cited by 15
Cognitive behavioral therapy (CBT) for preventing Alzheimer’s disease
Reid, L. D., Avens, F. E., & Walf, A. A. (2017) · Behavioural Brain Research · doi:10.1016/j.bbr.2017.07.024 · Cited by 16
Genetic Complexity of Early-Onset Alzheimer’s Disease
Ghani, M., Reitz, C., George‐Hyslop, P. S., & Rogaeva, E. A. (2018) · Springer eBooks · doi:10.1007/978-3-319-72938-1_3 · Cited by 15
An inclusive study of recent advancements in Alzheimer's disease: A comprehensive review
Singh, S., Mahajan, M., Kumar, D., Singh, K., Chowdhary, M., & Amit (2023) · Neuropeptides · doi:10.1016/j.npep.2023.102369 · Cited by 15
Deciphering the Role of Selenoprotein M
Nunes, L. G. A., Cain, A., Comyns, C., Hoffmann, P. R., & Krahn, N. (2023) · Antioxidants · doi:10.3390/antiox12111906 · Cited by 15
Rojas-Charry, L., Calero-Martinez, S. A., Morganti, C., Morciano, G., Park, K., Hagel, C., Marciniak, S. J., Glatzel, M., Pinton, P., & Falla, D. S. (2020) · Scientific Reports · doi:10.1038/s41598-020-63254-7 · Cited by 14
Moreno, J., Lanau, A. V., Madrigal, L., Pineda, A. Y. B., Hernandez, J. V., Campo, O., Soto-Ospina, A., Marín, P. A., Rishishwar, L., Norris, E. T., et al. (2022) · PLoS ONE · doi:10.1371/journal.pone.0269955 · Cited by 14
Martins, S., Müller‐Schiffmann, A., Erichsen, L., Bohndorf, M., Wruck, W., Sleegers, K., Broeckhoven, C. V., Korth, C., & Adjaye, J. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21124516 · Cited by 14
Self-citationBelfiori-Carrasco, L. F., Marcora, M. S., Bocai, N. I., Ceriani, M. F., Morelli, L., & Castaño, E. M. (2017) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2017.00061 · Cited by 14
TM2D genes regulate Notch signaling and neuronal function in Drosophila
Salazar, J. L., Yang, S.-A., Lin, Y. Q., Li-Kroeger, D., Marcogliese, P. C., Deal, S. L., Neely, G. G., & Yamamoto, S. (2021) · PLOS Genetics · doi:10.1371/journal.pgen.1009962 · Cited by 13
Li, Z., Min, S., Alliey‐Rodriguez, N., Giase, G. M., Cheng, L., Craig, D. W., Faulkner, G. J., Asif, H., Liu, C., & Gershon, E. S. (2022) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2022.12.002 · Cited by 14
Genomic Insights into Dementia: Precision Medicine and the Impact of Gene-Environment Interaction
Tripathi, A., Pandey, V. K., Sharma, G., Sharma, A. R., Taufeeq, A., Jha, A. K., & Kim, J. (2024) · Aging and Disease · doi:10.14336/ad.2024.0322 · Cited by 13
Tehrani, M. J., Matsuda, I., Yamagata, A., Kodama, Y., Matsunaga, T., Sato, M., Toyooka, K., McElheny, D., Kobayashi, N., Shirouzu, M., et al. (2024) · Nature Communications · doi:10.1038/s41467-024-51294-w · Cited by 14
Recent advances in the natural product analogues for the treatment of neurodegenerative diseases
Zhang, J., Jiang, P., Wang, S., Li, M., Hao, Z., Guan, W., Pan, J., Wu, J., Zhang, Y., Li, H. L., et al. (2024) · Bioorganic Chemistry · doi:10.1016/j.bioorg.2024.107819 · Cited by 13
Lin, Y., Cheng, C., Liao, Y., Hong, C., & Fuh, J. (2020) · Scientific Reports · doi:10.1038/s41598-020-76794-9 · Cited by 13
Lyons, C. E., Zhou, X., Razzoli, M., Chen, M., Xia, W., Ashe, K. H., Zhang, B., & Bartolomucci, A. (2021) · European Journal of Neuroscience · doi:10.1111/ejn.15329 · Cited by 14
Presenilin1 inhibits glioblastoma cell invasiveness via promoting Sortilin cleavage
Yang, W., Xiang, Y., Liao, M., Wu, P.-F., Yang, L., Huang, G., Shi, B., Liang, Y., & Lv, S. (2021) · Cell Communication and Signaling · doi:10.1186/s12964-021-00780-5 · Cited by 13
Kim, M., & Борисович, Б. И. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms24032092 · Cited by 13
Effects of donepezil on liver and kidney functions for the treatment of Alzheimer’s disease
Erbayraktar, Z., EVLİCE, A. T., Yener, G., & Ulusu, N. N. (2017) · Journal of Integrative Neuroscience · doi:10.3233/jin-170020 · Cited by 13
Ling, J., Huang, Y., Zhang, L., Wei, D., & Cheng, W. (2017) · Neuroscience Letters · doi:10.1016/j.neulet.2017.08.057 · Cited by 13
Cathepsin D: A Candidate Link between Amyloid ?-protein and Tauopathy in Alzheimer Disease
Suire, C. N., & Leissring, M. A. (2021) · Journal of Experimental Neurology · doi:10.33696/neurol.2.029 · Cited by 15
Álvarez‐Mora, M. I., Blanco-Palmero, V. A., Quesada‐Espinosa, J. F., Arteche‐López, A., Velasco, S. L., Milla, C. P., Rosales, J. M. L., Gómez-Manjón, I., Hernández‐Laín, A., Almonacid, J. J., et al. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23084230 · Cited by 13
Insights for Alzheimer's disease pharmacotherapy and current clinical trials
do Nascimento, A. L. C. S., Fernandes, R. P., Carvalho, A. C. S., Frigieri, I., Alves, R. C., & Chorilli, M. (2022) · Neurochemistry International · doi:10.1016/j.neuint.2022.105401 · Cited by 13
Apolipoprotein B as a New Link Between Cholesterol and Alzheimer Disease
Ishii, M. (2019) · JAMA Neurology · doi:10.1001/jamaneurol.2019.0212 · Cited by 13
Yang, X., Yao, K., Zhang, M., Zhang, W., & Zu, H. (2025) · Brain Research Bulletin · doi:10.1016/j.brainresbull.2025.111321 · Cited by 12
Dementia-related genetic variants in an Italian population of early-onset Alzheimer’s disease
Bartoletti‐Stella, A., Tarozzi, M. E., Mengozzi, G., Asirelli, F., Brancaleoni, L., Mometto, N., Maserati, M. S., Baiardi, S., Linarello, S., Spallazzi, M., et al. (2022) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2022.969817 · Cited by 12
Sanders, O. D. (2022) · Journal of Alzheimer s Disease Reports · doi:10.3233/adr-220047 · Cited by 13
Untangle the mystery behind DS-associated AD – Is APP the main protagonist?
Elangovan, A., Babu, H. W. S., Iyer, M., Gopalakrishnan, A. V., & Vellingiri, B. (2023) · Ageing Research Reviews · doi:10.1016/j.arr.2023.101930 · Cited by 12
Alzheimer's disease approaches - Focusing on pathology, biomarkers and clinical trial candidates
Hroudová, J., & Fišar, Z. (2024) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2024.111069 · Cited by 13
Kang, S., Lee, J., Ali, D. N., Choi, S. H., Nesbitt, J. J., Min, H.-K. P., Trushina, E. V., & Choi, D. (2024) · Scientific Reports · doi:10.1038/s41598-024-75202-w · Cited by 16
Korbolina, E. E., Александровна, Ж. А., Фурсова, А. Ж., Kozhevnikova, O. S., & Kolosova, N. G. (2016) · BMC Genetics · doi:10.1186/s12863-016-0461-7 · Cited by 12
Risk Variants in Three Alzheimer’s Disease Genes Show Association with EEG Endophenotypes
Macedo, A., Gómez, C., Rebelo, M. Â., Poza, J., Gomes, I., Martins, S., Maturana-Candelas, A., Pablo, V. G.-D., Durães, L., Sousa, P., et al. (2021) · Journal of Alzheimer s Disease · doi:10.3233/jad-200963 · Cited by 13
A Revisit to Etiopathogenesis and Therapeutic Strategies in Alzheimer’s Disease
Kumar, M., & Bansal, N. (2021) · Current Drug Targets · doi:10.2174/1389450122666211118125233 · Cited by 14
Conformational Models of APP Processing by Gamma Secretase Based on Analysis of Pathogenic Mutations
Kim, M., & Борисович, Б. И. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms222413600 · Cited by 13
Volonté, C., Hu, G., Shaw, C. A., Claudio, V. J., dos Santos, J. A., Vaz, S. H., Sebastião, A. M., Balcar, V. J., Mozley, P. D., Verde, F., et al. (2026) · Exploration of Neuroprotective Therapy · doi:10.37349/ent.2026.1004136 · Cited by 12
Krishna-K, K., Behnisch, T., & Sajikumar, S. (2022) · Journal of Alzheimer s Disease · doi:10.3233/jad-215718 · Cited by 10
Xiao, X., Liu, H., Zhou, L., Liu, X., Xu, T., Zhu, Y., Yang, Q., Hao, X., Liu, Y., Zhang, W., et al. (2022) · CNS Neuroscience & Therapeutics · doi:10.1111/cns.13987 · Cited by 11
Wang, K., Zhang, G., & Kuo, M. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms241914996 · Cited by 11
Production of a heterozygous exon skipping model of common marmosets using gene-editing technology
Sato, K., Sasaguri, H., Kumita, W., Sakuma, T., Morioka, T., Nagata, K., Inoue, T., Kurotaki, Y., Mihira, N., Tagami, M., et al. (2024) · Lab Animal · doi:10.1038/s41684-024-01424-0 · Cited by 12
An interpretable deep learning framework identifies proteomic drivers of Alzheimer’s disease
Panizza, E., & Cerione, R. A. (2024) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2024.1379984 · Cited by 11
Wang, N., Pan, Y., Starling, S. C., Haskell, D. H., Quintero, A. C., Kawatani, K., Inoue, Y., Shue, F., Ma, X., Aikawa, T., et al. (2025) · Alzheimer s & Dementia · doi:10.1002/alz.70112 · Cited by 11
Cheng, R., Tang, M., Martinez, I. M., Ayodele, T., Baez, P., Reyes‐Dumeyer, D., Lantigua, R., Medrano, M. Z., Jiménez‐Velázquez, I. Z., Lee, J. H., et al. (2018) · Alzheimer s & Dementia Diagnosis Assessment & Disease Monitoring · doi:10.1016/j.dadm.2018.07.007 · Cited by 11
Metadata
- Authors
- Cacace, R., Sleegers, K., & Van Broeckhoven, C.
- Affiliations
- University of Antwerp (BE)
- Neurodegenerative Brain Diseases group Department of Molecular Genetics VIB Antwerp Belgium
- Venue
- Alzheimer's & Dementia
- Publisher
- Wiley
- Published
- 2016-03-23
- Volume
- 12
- Issue
- 6
- Pages
- 733-748
- ISSN
- 1552-5260 (ISSN-L)
- 1552-5279
- OpenAlex
- W2306696647
- Cited by
- 617
- References
- 167
- Citations by year
- 2026: 34 · 2025: 71 · 2024: 60 · 2023: 90 · 2022: 85 · 2021: 88 · 2020: 61 · 2019: 49 · 2018: 35 · 2017: 32 · 2016: 11
- FWCI
- 4.97
- Type
- journal article
- Language
- en
- Open access
- hybrid
- doi.org
- Licence
- Locations
- Alzheimer s & Dementia (publishedVersion, cc-by-nc-nd)
- PubMed (publishedVersion)
- Funders
- Fonds Wetenschappelijk Onderzoek
- Topics
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Alzheimer's disease research and treatments
- Health Sciences › Medicine › Psychiatry and Mental health › Dementia and Cognitive Impairment Research
- Health Sciences › Medicine › Clinical Neurology › Amyotrophic Lateral Sclerosis Research
- Keywords
- early-onset Alzheimer's disease, familial Alzheimer's disease
- MeSH terms
- Alzheimer Disease, Apolipoproteins E, Humans, Models, Molecular, Molecular Biology, Mutation, Amyloid beta-Protein Precursor, Presenilin-1, Presenilin-2
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
